Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP (Q30569917)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 October 2017

Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP (English)

1 reference

Europe PubMed Central

29 October 2017

hospitalization

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

author name string

Anne Haeberle

1

1 reference

Europe PubMed Central

29 October 2017

Waldemar Greil

2

1 reference

Europe PubMed Central

29 October 2017

Stefan Russmann

3

1 reference

Europe PubMed Central

29 October 2017

Renate Grohmann

4

1 reference

Europe PubMed Central

29 October 2017

publication date

21 September 2012

1 reference

Europe PubMed Central

29 October 2017

1 reference

Europe PubMed Central

29 October 2017

12

1 reference

Europe PubMed Central

29 October 2017

153

1 reference

Europe PubMed Central

29 October 2017

https://scigraph.springernature.com/pub.10.1186/1471-244x-12-153

0 references

Antidepressant treatment for acute bipolar depression: an update.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Quetiapine for bipolar depression: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Bipolar depression: overview and commentary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Clinical practice recommendations for bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

The use of antidepressants in bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Treatment of bipolar depression: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Effectiveness of adjunctive antidepressant treatment for bipolar depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

International Consensus Group on Bipolar I Depression Treatment Guidelines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

The AMSP drug safety program: methods and global results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514299

20 June 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Extending indications for long-term pharmacotherapy: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Antidepressants in bipolar depression: the clinical debate.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-153

21 January 2018

International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22998655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the treatment of patients with bipolar disorder (revision)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22998655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Research methods in drug surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22998655

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-12-153

1 reference

Europe PubMed Central

29 October 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-244x-12-153

1 reference

Europe PubMed Central

29 October 2017

1 reference

Europe PubMed Central

29 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30569917&oldid=2066731675"